Hyperfine, Inc. (HYPR) stock

HYPRNasdaqElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 9, 2026Score 7/3019% below fair value

$0.63−0.05 (-7.36%)

Close on Nov 13, 2026Market cap $66.74MP/E –Yield –

Hyperfine operating margin

Operating margin is operating income as a percentage of revenue.

Hyperfine's operating margin for the twelve months ending Sep 30, 2026 was -167.6%. For fiscal 2025 it was -273.4%, against -335.3% the year before. The highest annual figure on record is -273.4% in fiscal 2025.

Annual operating margin

Period	Period end	Value	Change (pts)
FY2025	Dec 31, 2025	-273.4%	+61.9
FY2024	Dec 31, 2024	-335.3%	+100.8
FY2023	Dec 31, 2023	-436.1%	+648.0
FY2022	Dec 31, 2022	-1084.2%	+3251.9
FY2021	Dec 31, 2021	-4336.1%	+3654.0
FY2020	Dec 31, 2020	-7990.1%	–

Quarterly operating margin

Change is against the same quarter a year earlier.

Period	Period end	Value	Change (pts)
Q3 FY2026	Sep 30, 2026	-121.8%	+137.8
Q2 FY2026	Jun 30, 2026	-216.9%	+139.0
Q1 FY2026	Mar 31, 2026	-219.3%	+290.9
Q4 FY2025	Dec 31, 2025	-144.9%	+318.9
Q3 FY2025	Sep 30, 2025	-259.5%	+41.4
Q2 FY2025	Jun 30, 2025	-355.9%	−57.2
Q1 FY2025	Mar 31, 2025	-510.2%	−186.9
Q4 FY2024	Dec 31, 2024	-463.8%	−30.9
Q3 FY2024	Sep 30, 2024	-300.9%	+203.7
Q2 FY2024	Jun 30, 2024	-298.7%	+47.1
Q1 FY2024	Mar 31, 2024	-323.2%	+171.5
Q4 FY2023	Dec 31, 2023	-432.9%	+524.1
Q3 FY2023	Sep 30, 2023	-504.7%	+61.0
Q2 FY2023	Jun 30, 2023	-345.8%	+1167.0
Q1 FY2023	Mar 31, 2023	-494.7%	+1080.6
Q4 FY2022	Dec 31, 2022	-957.1%	+5026.2
Q3 FY2022	Sep 30, 2022	-565.7%	+3852.1
Q2 FY2022	Jun 30, 2022	-1512.9%	+2561.5
Q1 FY2022	Mar 31, 2022	-1575.3%	+782.7
Q4 FY2021	Dec 31, 2021	-5983.3%	–
Q3 FY2021	Sep 30, 2021	-4417.8%	–
Q2 FY2021	Jun 30, 2021	-4074.3%	–
Q1 FY2021	Mar 31, 2021	-2358.0%	–